Low glycemic sugar composition
AssigneeGlobal Biolife Inc.
InventorDaryl THOMPSON
Life of this patent
Estimating the term…
Abstract
A composition includes a sugar source and inositol. The sugar source is one more sugars select from the group consisting of glucose, sucrose, sucrolose, tagatose, galactose, high fructose corn syrup, fructose, isoglucose, and rhamnose. The composition of sugar and inositol has an unique properties that prevents or limits the signaling of TNF-α and associated pro-inflammatory cytokines when metabolized by an individual consuming the composition. Accordingly, the composition can be advantageously used to control blood glucose levels, treat diabetes and related conditions as well as treat diseases based on an inflammatory response.
Claims20
A composition consisting of a sugar and inositol.
A composition consisting essentially of a sugar and inositol with anti-TNF-α effects when administered to a patient in need of treatment therefrom.
11-13. (canceled)
A method of treating or limiting the occurrence of diabetes, said method comprising administering a therapeutically effective amount of a composition consisting essentially of sugar and inositol to an individual in need to treatment therefrom to thereby treat or limit the occurrence of diabetes by mitigating effects of TNF-α.
A method of treating or limiting the occurrence of disease conditions based on an inflammatory response, said method comprising administering a therapeutically effective amount of a composition consisting essentially of sugar source and inositol to an individual in need to treatment therefrom to thereby treat or limit the occurrence of an inflammatory disease condition by mitigating effects of TNF-α.
Dependencies are inferred from the claim text.